IP Library Granted Patent US 9,802,992
Granted Patent B2
US 9,802,992 · App. 12/086,124 · Granted Oct 31, 2017

Cell into which protein, which can serve as polymerization nucleus of protein polymer, or polymer thereof is introduced, and method for production of the cell

Inventors: Takashi Nonaka (Tokyo, JP); Sayuri Watanabe (Amagasaki, JP); Masami Masuda (Fujimi, JP); Masato Hasegawa (Chofu, JP)
Assignee: TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE
C07K14/47C12N5/0619C12N5/0622G01N33/5058G01N33/6896C12N2503/02C12N2510/00G01N2500/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,802,992
App. No.
12/086,124
Granted
Oct 31, 2017
Kind
B2
Abstract

The present invention has the object of providing a cell into which a protein, which can serve as a polymerization nucleus of a protein polymer, or polymer thereof is introduced, and a method for producing the cell. The invention relates to a cell into which a protein, which can serve as a polymerization nucleus of a protein polymer, or a polymer thereof is introduced, a method for producing the cell, and a method of screening for a compound inhibiting an intracellular accumulation of a protein containing fibril structures, wherein the method comprises bringing a candidate substance into contact with the cell.

Claims (8)

1. A method for producing a cellular model of α-synuclein inclusion formation by polymerization, wherein the method comprises:

introducing into a neuron or a glial cell, by use of a lipid transport reagent, an α-synuclein fibril formed from α-synuclein of SEQ ID NO: 2 or a mutant thereof at A30P, A53T, or E46K or a variant thereof with portion(s) deleted in any or all of the amino acid residues at positions 10 to 15, 21 to 26, 32 to 37, 43 to 48, and 58 to 63, said α-synuclein fibril being a suitable polymerization nucleus of filamentous α-synuclein inclusions;

introducing into a neuron or a glial cell an expression vector encoding a recombinant α-synuclein of SEQ ID NO: 2 or a mutant thereof at A30P, A53T, or E46K or a variant thereof with portion(s) deleted in any or all of the amino acid residues at positions 10 to 15, 21 to 26, 32 to 37, 43 to 48, and 58 to 63; and

thereby causing interaction between the α-synuclein fibril and the recombinant α-synuclein generated by expression of the vector forming filamentous α-synuclein inclusions in the cell by polymerization,

wherein the α-synuclein fibril which can serve as a polymerization nucleus and the recombinant α-synuclein generated in the cell are phosphorylated in the cell.

2. The method according to claim 1 , wherein the expression plasmid comprises the polynucleotide having the sequence set forth in SEQ ID NO: 1, which encodes the α-synuclein having the polypeptide sequence set forth in SEQ ID NO: 2.

3. The method according to claim 1 , wherein the α-synuclein fibril or the recombinant α-synuclein comprises a variant of α-synuclein having amino acid residue 30 of SEQ ID NO: 2 substituted with proline; having amino acid residue 46 of SEQ ID NO: 2 substituted with lysine; or having amino acid residue 53 of SEQ ID NO: 2 substituted with threonine.

4. The method according to claim 1 , wherein the lipid transport regent is a 3:1 (w/w) formulation of the polycationic lipid 2,3-dioleyloxy-N-[2(sperminecarboxamido)ethyl]-N,N-dimethyl-1-propanaminium trifluoroacetate (DOSPA) and the neutral lipid dioleoyl phosphatidylethanolamine (DOPE).

Assignments (2)
CHANGE OF NAME Recorded Sep 7, 2011
From: TOKYO METROPOLITAN ORGANIZATION FOR MEDICAL RESEARCH
To: TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE
Reel/Frame 026865/0615 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2008
From: NONAKA, TAKASHI; WATANABE, SAYURI; MASUDA, MASAMI; HASEGAWA, MASATO
To: TOKYO METROPOLITAN ORGANIZATION FOR MEDICAL RESEARCH
Reel/Frame 021975/0515 →
Priority Claims (1)
JP 2005-352486 · Dec 6, 2005 · national
Continuity (1)
Related Publication 20100047826A1 · Feb 25, 2010